|
CAS No.
|
Product Name
|
|
34157-83-0
|
Celastrol(Tripterin); tripterine; (2R,4aS,6aS,6aR,14aS,14bR)-10-Hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid; (9β,13α,14β,20α)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid; 3-Hydroxy-9β,13α-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid; 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid; NSC70931; 10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-picene-2-carboxylic acid
|
|
1258-84-0
|
Pristimerin(NSC 99281);(9b,13a,14b,20a)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tertraen-29-oic acid methyl ester; Celastrol methyl ester; (9β,13α,14β,20α)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid methyl ester; 3-hydroxy-9β,13α-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid, methyl ester
|
|
38748-32-2
|
Triptolide(TPL);PG490 ; PG 490 ; PG-490;(3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-3b,4,4a,6,6a,7a,7b,8b,9,10-Decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)trisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-1(3H)-one
|
|
38647-10-8
|
Tripdiolide;Triptodiolide
|
|
37239-51-3
|
Wilfordine;Wilfordin;(8R,9R,10R,11S,12S,13R,14R,15S,21S,22S,23R)-10,13,22,23-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-18,21-dihydroxy-8,18,21-trimethyl-,8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione;8,11-Epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione,10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-18,21-dihydroxy-8,18,21-trimethyl-,(8R,9R,10R,11S,12S,13R,14R,15S,21S,22S,23R)-
|
|
37239-47-7
|
Wilforgine;Wilforgin; Evonimine, 8-(acetyloxy)-O2-deacetyl-8-deoxo-O2-(3-furanylcarbonyl)-, (8α)-;3-Furancarboxylic acid, 10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-21-hydroxy-8,18,21-trimethyl-5,17-dioxo-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridin-14-yl ester, (8R,9R,10R,11S,12S,13R,14R,15S,18S,21S,22S,23R)-;(8alpha)-8-(Acetyloxy)-O2-deacetyl-8-deoxo-O2-(3-furanylcarbonyl)- evonimine Wilforgin; 3-Furancarboxylic acid (8R,9R,10R,11S,12R,13R,14R,15S,18S,21S,22S,23R)-10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-21-hydroxy-8,18,21-trimethyl-5,17-dioxo-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridin-14-yl ester;AIDS088959; AIDS-088959;BRN 0078231; Evonimine, 8-(acetyloxy)-O(sup 2)-deacetyl-8-deoxo-O(sup 2)-(3-furanylcarbonyl)-, (8-alpha)-
|
|
11088-09-8
|
Wilforine;26-Deoxywilfordine; Evonimine, 8-(acetyloxy)-O2-benzoyl-O2-deacetyl-8-deoxo-, (8α)-;8,11-Epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione, 10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-21-hydroxy-8,18,21-trimethyl-, (8R,9R,10R,11S,12S,13R,14R,15S,18S,21S,22S,23R)-;(8R,9R,10R,11S,12S,13R,14R,15S,18S,21S,22S,23R)-10,13,22,23-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-21-hydroxy-8,18,21-trimethyl-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione
|
|
37239-48-8
|
Wilfortrine;Wilfortrin;3-Furancarboxylic acid,(8R,9R,10R,11S,12R,13R,14R,15S,21S,22S,23R)-10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-18,21-dihydroxy-8,18,21-trimethyl-5,17-dioxo-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridin-14-ylester
|
|
345954-00-9
|
Wilfornine A;8,11-Epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione, 10,13,14,22,23-pentakis(acetyloxy)-12-[(acetyloxy)methyl]-18-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-21-hydroxy-8,18,21-trimethyl-, (8R,9R,10R,11S,12R,13R,14R,15S,21S,22S,23R)-
|
|
168009-85-6
|
Triptonine B; Triptonine B (Tripterygium wilfordii); (-)-Triptonine B; 18-O-(3-Furoyl)wilfortrine; Wilfortrine 26-(3-furoate); 3-Furancarboxylic acid, 10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-21-hydroxy-8,18,21-trimethyl-5,17-dioxo-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H[1,9]dioxacyclooctadecino[4,3-b]pyridine-14,18-diylester, (8R,9R,10R,11S,12R,13R,14R,15S,18R,21S,22S,23R)-
|
|
84104-71-2
|
Wilforlide A
|
|
38647-11-9
|
Triptonide;(3bS,4aS,5aS,6aS,7aS,7bS,8aS,8bS)-6a-Isopropyl-8b-methyl-3b,4,4a,7a,7b,8b,9,10-octahydrotrisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-1,6(3H,6aH)-dione;NSC 165677; PG 492
|
|
107316-88-1
|
Demethylzeylasteral; (9beta,13alpha,14beta,20alpha)-2,3-Dihydroxy-9,13-dimethyl-6,23-dioxo-24,25,26-trinoroleana-1,3,5(10),7-tetraen-29-oic acid
|
|
74285-86-2
|
Triptophenolide;(+)-Triptophenolide; Hypolide; (3bR,9bS)-3b,4,5,9b,10,11-Hexahydro-6-hydroxy-9b-methyl-7-(1-methylethyl)phenanthro[1,2-c]furan-1(3H)-one
|
|
61276-17-3
|
Acteoside;Verbascoside;[(2R,3R,4R,5R,6R)-6-[2-(3,4-Dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate;Kusaginin; Russetinol; Stereospermin; TJC 160; NSC 603831; β-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-α-L-mannopyranosyl)-, 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]
|
|
61303-13-7
|
Isoacteoside; Isoverbascoside; [(2R,3R,4S,5R,6R)-5-(3,4-Dihydroxyphenyl)-6-ethoxy-3,5-dihydroxy-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate;β-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-α-L-mannopyranosyl)-, 6-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]
|
|
989-51-5
|
(-)-Epigallocatechin gallate (EGCG);(2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate); (-)-Epigallocatechin gallate 3-O-gallate;(-)-Epigallocatechin Gallate
|
|
62284-79-1
|
(-)-p-Bromotetramisole oxalate;L-p-Bromotetramisole oxalate; 6-Bromolevamisole oxalate; (-)-p-Bromolevamisole oxalate
|
|
N/A
|
(1S,3R,5R)-PIM447 dihydrochloride; (1S,3R,5R)-LGH447 dihydrochloride
|
|
1820565-69-2
|
PIM-447 dihydrochloride;LGH-447 dihydrochloride;N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide
|
|
1210608-43-7
|
PIM447;LGH447; PIM-447; LGH-447; PIM 447; LGH 447
|
|
30636-90-9
|
(20S)-Protopanaxadiol; 20-Epiprotopanaxadiol; 20(S)-APPD
|
|
N/A
|
(Ac)Phe-Lys(Alloc)-PABC-PNP
|
|
334-49-6
|
(E)-2-Decenoic acid; trans-2-Decenoic acid;trans-2-Decylenic Acid;(E)-dec-2-enoic acid
|
|
15790-91-7
|
(Z)-2-Decenoic acid; cis-2-Decenoic acid;(Z)-dec-2-enoic acid
|
|
878006-06-5
|
(E)-[6]-Dehydroparadol
|
|
27113-22-0
|
Paradol;[6]-Gingerone; [6]-Paradol;Heptyl 4-hydroxy-3-methoxyphenethyl ketone
|
|
19685-09-7
|
(S)-10-Hydroxycamptothecin; 10-HCPT; 10-Hydroxycamptothecin;(4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxycamptothecine; NSC 107124
|
|
150145-89-4
|
(S)-MCPG;(+)-MCPG;(S)-α-Methyl-4-carboxyphenylglycine;4-[(1S)-1-Azaniumyl-1-Methyl-2-Oxido-2-Oxo-Ethyl]Benzoate; 4-[(1S)-1-Ammonio-1-Methyl-2-Oxido-2-Oxoethyl]Benzoate; 4-[(1S)-1-Ammonio-2-Keto-1-Methyl-2-Oxido-Ethyl]Benzoate;(alphaS)-alpha-Amino-4-Carboxy-alpha-Methyl-Benzeneacetic Acid
|
|
146669-29-6
|
(RS)-MCPG;(±)-MCPG;(RS)-α-Methyl-4-carboxyphenylglycine;4-[(1R)-1-Azaniumyl-1-Methyl-2-Oxido-2-Oxo-Ethyl]Benzoate; 4-[(1R)-1-Ammonio-1-Methyl-2-Oxido-2-Oxoethyl]Benzoate; 4-[(1R)-1-Ammonio-2-Keto-1-Methyl-2-Oxido-Ethyl]Benzoate;alpha-Amino-4-Carboxy-alpha-Methyl-Benzeneacetic Acid
|
|
1189561-66-7
|
(S)-Gossypol acetic acid;(S)-(+)-Gossypol acetic acid
|
|
866541-93-7
|
AT-101 acetic acid;(R)-(-)-Gossypol acetic acid; (-)-Gossypol acetic acid; (R)-Gossypol acetic acid;(R)-Gossypol acetic acid
|
|
90141-22-3
|
AT-101;(R)-(-)-Gossypol; R-(-)-gossypol acetic acid; AT 101; AT101;(-)-Gossypol;(R)-Gossypol; (R)-1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-[2,2'-binaphthalene]-8,8'-dicarboxaldehyde
|
|
66389-74-0
|
(+)-Apogossypol; Apogossypol; NSC736630
|
|
287194-41-6
|
(+)-DHMEQ;(1R,2R,6R)-Dehydroxymethylepoxyquinomicin; (1R,2R,6R)-DHMEQ
|
|
287194-40-5
|
(-)-DHMEQ;Dehydroxymethylepoxyquinomicin;Dehydroxymethylepoxyquinomicin (DHMEQ)
|
|
287194-38-1
|
DHMEQ racemate;rel-DHMEQ
|
|
221243-82-9
|
1-Naphthyl PP1;1-NA-PP 1; 1-(1,1-Dimethylethyl)-3-(1-naphthalenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
956025-47-1
|
1-Naphthyl PP1 hydrochloride;1-NA-PP 1 hydrochloride
|
|
221244-14-0
|
1-NM-PP1; PP1 Analog II; 1-NM-PP 1;1 NM-PP1; 4-Amino-1-tert-butyl-3-(1'-naphthylmethyl)pyrazolo[3,4-d]pyrimidine
|
|
32981-86-5(92999-93-4)
|
10-Deacetyl Baccatin III (10-DAB III);10-Deacetylbaccatin III; 10-Deacetylbaccatine III;10 DAB III;10-DAB;12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,6,9,11-tetrahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one
|
|
167074-97-7
|
10-Oxo Docetaxel;Docetaxel Impurity
|
|
403811-55-2
|
10058-F4;10058F4;5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone
|
|
1430089-64-7
|
2,4-Pyrimidinediamine with linker;N2-[4-[(3-Aminopropyl)amino]phenyl]-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine
|
|
163042-96-4
|
2-Cl-IB-MECA; Chloro-IB-MECA; CF-102; CI-IB-MECA;1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-beta-D-ribofuranuronamide;2-Chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide
|
|
154-17-6
|
2-Deoxy-D-glucose;2-Deoxy-D-arabino-hexose; D-Arabino-2-deoxyhexose;2-Deoxyglucose;(4R,5S,6R)-6-(hydroxymethyl)oxane-2,4,5-triol
|
|
362-07-2
|
2-Methoxyestradiol; 2-ME2; NSC-659853
|
|
85999-40-2
|
23-Hydroxybetulinic acid;Anemosapogenin;3beta,23-Dihydroxylup-20(29)-en-28-oic acid
|
|
180288-69-1
|
Anti HER2, Ig gamma-1 chain C region;Recombinant humanized anti-HER2 antibody;Trastuzumab;RhuMab HER2
|
|
205923-56-4
|
C 225; EGFR antibody; IMC 225; IMC-C 225;Cetuximab
|
|
185243-69-0
|
rhu-TNFR-Fc; Etanercept;rhuTNFR: Fc
|
|
1968-05-4
|
3,3'-Diindolylmethane;DIM; 3,3'-Methylenebisindole
|
|
1113-59-3
|
3-Bromopyruvic acid;Bromopyruvic acid; Hexokinase II Inhibitor II, 3-BP
|
|
5142-23-4
|
3-Methyladenine(3-MA); 6-Amino-3-methylpurine;3-Methyl-6-aminopurine; N3-Methyladenine; NSC 66389
|
|
794458-56-3
|
360A;3,3'-[2,6-Pyridinediylbis(carbonylimino)]bis[1-methylquinolinium]
|
|
737763-37-0
|
360A iodide;360 A iodide;3,3'-[2,6-Pyridinediylbis(carbonylimino)]bis[1-methylquinolinium] diiodide
|
|
28755-03-5
|
3CAI; 3 CAI; 3-CAI; 2-Chloro-1-(3-Indolyl)-Ethanone
|
|
18550-98-6
|
3PO;3PO (inhibitor of glucose metabolism)
|
|
68047-06-3
|
4-Hydroxytamoxifen;(Z)-4-Hydroxytamoxifen; trans-4-Hydroxytamoxifen;(Z)-4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol
|
|
155798-08-6
|
4-IBP;4 IBP; 4IBP;N-(N-Benzylpiperidin-4-yl)-4-iodobenzamide
|
|
328998-25-0
|
4E1RCat; 4-[2,3-Dihydro-3-[[5-(4-nitrophenyl)-2-furanyl]methylene]-2-oxo-5-phenyl-1H-pyrrol-1-yl]benzoic acid;4-[(3E)-3-[[5-(4-Nitrophenyl)furan-2-yl]methylidene]-2-oxo-5-phenyl-2,3-dihydro-1H-pyrrol-1-yl]benzoic acid
|
|
315706-13-9
|
4EGI-1; alpha-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl]hydrazinylidene]-2-nitrobenzenepropanoic acid; α-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl]hydrazinylidene]-2-nitro-benzenepropanoic acid
|
|
218916-52-0
|
5,15-Diacetyl-3-benzoyllathyrol; (1aR,2E,4aR,6S,7S,7aR,8R,11aS)-4a,8-Bis(acetyloxy)-7-(benzoyloxy)-1,1a,4a,5,6,7,7a,8,9,10,11,11a-dodecahydro-1,1,3,6-tetramethyl-9-methylene-4H-cyclopenta[a]cyclopropa[f]cycloundecen-4-one; Diacetyl Benzoyl Lathyrol; Euphorbia factor L3; Phytoclear EL-1
|
|
320-67-2
|
Azacitidine(5-Azacytidine);Ladakamycin; 5-AzaC;4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one
|
|
51-21-8
|
5-Fluorouracil(5-FU);5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidine-2,4-dione
|
|
24386-93-4
|
5-Iodotubercidin;5-Iodo-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine;7-Deaza-7-iodoadenosine;NSC 113939; 5-Itu
|
|
484-20-8
|
5-Methoxypsoralen;Bergapten;4-Methoxy-7H-furo[3,2-g]chromen-7-one;8-Demethoxyisoimpinellin; Bergaptan; Bergaptene; Geralen; Heraclin; Majudin; NSC 95437; Psoraderm
|